Keizo Koya serves as Executive at SYNTA PHARMACEUTICALS CORP, where they oversee executive responsibilities. Since joining the company, Keizo Koya has executed 7 insider transactions totaling $272.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 1, 2012 involved selling 6,844 shares valued at $32.2K.
Keizo Koya currently holds 12,999 shares of SYNTA PHARMACEUTICALS CORP (SNTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Keizo Koya has been a net seller of SNTA stock. They have purchased $28.4K and sold $243.7K worth of shares.
Keizo Koya's most recent insider trade was on Mar 1, 2012, when they sold 6,844 shares at $4.70 per share.
Get notified when new Form 4 filings are submitted
| $6.00 |
| Discretionary |
| Apr 20, 2011 | SNTA | $56.0K | Sale | 10,000 | $5.60 | Discretionary |
| Mar 1, 2011 | SNTA | $0 | Award | 6,844 | $N/A | Discretionary |
| Mar 1, 2011 | SNTA | $95.6K | Sale | 18,270 | $5.23 | Discretionary |
| Mar 1, 2010 | SNTA | $0 | Award | 8,224 | $N/A | Discretionary |
| Aug 24, 2009 | SNTA | $28.4K | Purchase | 10,000 | $2.84 | Discretionary |